Vaccine-elicited CD4 T Cells Prevent the Deletion of Antiviral B Cells in Chronic Infection
Overview
Authors
Affiliations
Chronic viral infections subvert protective B cell immunity. An early type I interferon (IFN-I)-driven bias to short-lived plasmablast differentiation leads to clonal deletion, so-called "decimation," of antiviral memory B cells. Therefore, prophylactic countermeasures against decimation remain an unmet need. We show that vaccination-induced CD4 T cells prevented the decimation of naïve and memory B cells in chronically lymphocytic choriomeningitis virus (LCMV)-infected mice. Although these B cell responses were largely T independent when IFN-I was blocked, preexisting T help assured their sustainability under conditions of IFN-I-driven inflammation by instructing a germinal center B cell transcriptional program. Prevention of decimation depended on T cell-intrinsic Bcl6 and Tfh progeny formation. Antigen presentation by B cells, interactions with antigen-specific T helper cells, and costimulation by CD40 and ICOS were also required. Importantly, B cell-mediated virus control averted Th1-driven immunopathology in LCMV-challenged animals with preexisting CD4 T cell immunity. Our findings show that vaccination-induced Tfh cells represent a cornerstone of effective B cell immunity to chronic virus challenge, pointing the way toward more effective B cell-based vaccination against persistent viral diseases.
Sun W, Zhu Y, Zou Z, Wang L, Zhong J, Shen K Theranostics. 2024; 14(5):2127-2150.
PMID: 38505619 PMC: 10945348. DOI: 10.7150/thno.91626.
Florova M, Abreu-Mota T, Paesen G, Beetschen A, Cornille K, Marx A Proc Natl Acad Sci U S A. 2024; 121(11):e2318657121.
PMID: 38446855 PMC: 10945855. DOI: 10.1073/pnas.2318657121.
Multiantigen pan-sarbecovirus DNA vaccines generate protective T cell immune responses.
van Bergen J, Camps M, Pardieck I, Veerkamp D, Leung W, Leijs A JCI Insight. 2023; 8(21).
PMID: 37707962 PMC: 10721273. DOI: 10.1172/jci.insight.172488.
Adoptive B cell therapy for chronic viral infection.
Chung Y, Dangi T, Palacio N, Sanchez S, Penaloza-MacMaster P Front Immunol. 2022; 13:908707.
PMID: 35958615 PMC: 9361846. DOI: 10.3389/fimmu.2022.908707.